Description
GEMER DAPA XR 10/1/500 Tablet is a triple combination of Dapagliflozin, Glimepiride, and Metformin Hydrochloride in an extended-release formulation for comprehensive type 2 diabetes management. This combination provides enhanced glycemic control through multiple complementary mechanisms with once-daily dosing convenience. GEMER DAPA XR 10/1/500 Tablet is available in extended-release tablet form for oral administration. Use the product according to the instructions provided on the packaging or as advised by a healthcare professional. Please read the product label carefully and follow all recommended precautions and warnings before using this medicine. Important Note: This information is for general product purposes only and is not intended as medical advice. Always consult a healthcare professional before use.
Reviews
There are no reviews yet.